This document is an excerpt from the EUR-Lex website
Document 22023D1253
Decision of the EEA Joint Committee No 311/2022 of 9 December 2022 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/1253]
Decision of the EEA Joint Committee No 311/2022 of 9 December 2022 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/1253]
Decision of the EEA Joint Committee No 311/2022 of 9 December 2022 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/1253]
PUB/2022/1580
OJ L 164, 29.6.2023, p. 37–38
(BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
Date of entry into force unknown (pending notification) or not yet in force.
|
29.6.2023 |
EN |
Official Journal of the European Union |
L 164/37 |
DECISION OF THE EEA JOINT COMMITTEE No 311/2022
of 9 December 2022
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/1253]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Implementing Decision (EU) 2022/1388 of 23 June 2022 on the unresolved objections regarding the terms and conditions of the authorisation of the biocidal product Pat’Appât Souricide Canadien Foudroyant referred by France and Sweden in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (1) is to be incorporated into the EEA Agreement. |
|
(2) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
The following point is inserted after point 12zzzzzzzz (Commission Implementing Decision (EU) 2022/323) of Chapter XV of Annex II to the EEA Agreement:
|
‘12zzzzzzzza. |
32022 D 1388: Commission Implementing Decision (EU) 2022/1388 of 23 June 2022 on the unresolved objections regarding the terms and conditions of the authorisation of the biocidal product Pat’Appât Souricide Canadien Foudroyant referred by France and Sweden in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 208, 10.8.2022, p. 7).’ |
Article 2
The text of Implementing Decision (EU) 2022/1388 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 10 December 2022, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 9 December 2022.
For the EEA Joint Committee
The President
Kristján Andri STEFÁNSSON
(1) OJ L 208, 10.8.2022, p. 7.
(*1) No constitutional requirements indicated.